October Pharma results, Q3 2022
Net profit, assets, equity and cash flow for Q3 2022, against the same period a year earlier, from the published financial statements.
Net profit109 millionEGP
Total assets849 millionEGP
Shareholders' equity404 millionEGP
Operating cash flow-77.15 millionEGP
In short
- October Pharma's net profit for Q3 2022 was about 109 million EGP.
- Total assets at the end of Q3 2022 were about 849 million EGP, and shareholders' equity about 404 million EGP.
- Operating cash flow for Q3 2022 was negative at 77.15 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit109 million——
Gross profit274 million——
Total assets849 million——
Total liabilities445 million——
Shareholders' equity404 million——
Total liabilities and equity849 million——
Operating cash flow-77.15 million——
Investing cash flow-73.29 million——
Financing cash flow146 million——
Net change in cash-4.03 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
October Pharma's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy